Therefore, the aim of this study was to assess whether baseline circulating CD4+ and CD8+ α4β7+ memory T cell subpopulations, several lymphocytic markers previously involved in the physiopathology of IBD (19, 20), and their changes during treatment could be predictors of response to VDZ in patients with UC. The gene discussed is CD8A; the disease is inflammatory bowel disease.